{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-038054","form_type":"8-K","ticker":"HTCR","cik":"0001892322","company_name":"HeartCore Enterprises, Inc.","filed_at":"2024-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.121680+00:00","generated_at":"2026-05-31T01:55:28.986821+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"SBC Medical Group begins trading on Nasdaq; HeartCore guides Q3 rev $19-23M, net profit $4-8M","bullets":["Go IPO client SBC Medical Group commenced trading on Nasdaq Global Market under symbol 'SBC'.","HeartCore generated $17.9M total revenue from SBC deal; $17M recognized in Q3 2024.","HeartCore holds $8M worth of SBC stock after IPO.","Q3 2024 guidance: revenue $19M-$23M, net profit $4M-$8M.","Sold $9M of warrants to a Japanese financial institution in Q1 2024; net sales $5.64M after referral fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-038054","json":"https://secwatch.observer/filing/0001493152-24-038054.json","markdown":"https://secwatch.observer/filing/0001493152-24-038054.md","text":"https://secwatch.observer/filing/0001493152-24-038054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/0001493152-24-038054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:55:28.986821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}